Selective isolation of in vitro phase II conjugates using a lipophilic anionic exchange solid phase extraction...

Area of Science:

• Pharmaceutical Chemistry
• Analytical Chemistry
• Drug Metabolism

Background:

• Accurate identification and characterization of drug metabolites are essential for assessing drug efficacy and safety.
• Current methods for metabolite isolation often involve complex, multi-step procedures requiring significant sample quantities.

Purpose of the Study:

• To develop a rapid, simple, and selective method for isolating phase II drug conjugates (glucuronides and sulfates) from parent compounds.
• To demonstrate the utility of mixed-phase anionic exchange lipophilic SPE cartridges for metabolite purification.

Main Methods:

• Utilized off-line mixed-phase anionic exchange lipophilic SPE cartridges for selective isolation of glucuronide and sulfate metabolites.
• Exploited pKa differences between parent compounds and anionic phase II conjugates for separation.
• Employed sequential elution with basic aqueous solution, methanol, and acidic methanolic solution to isolate metabolites.

Main Results:

• Successfully isolated over 100 µg of high-purity (>95%) glucuronide and sulfate metabolites.
• Demonstrated isolation of 17α-ethynylestradiol-3-glucuronide, 6-gingerol-4'-glucuronide, and DHBC conjugates.
• Confirmed metabolite structures using UPLC-QTof and nuclear magnetic resonance (NMR) analysis.

Conclusions:

• The developed SPE method provides a fast and efficient approach for purifying key drug metabolites.
• This technique simplifies metabolite isolation, enabling quicker characterization for drug development.
• The method's effectiveness was validated with various clinically relevant phase II conjugates.